Michael Burke MD has Psychiatry as his primary medical specialty. Their primary office is: 509 Sumter St in Montezuma, Georgia.
They're a part of the: Premier Healthcare Investments medical group which has around 7 members. You can call their office at 478-472-3100 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Medical College Of Georgia School Of Medicine and graduated in 1989 (around 35 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
Michael Burke MD
Premier Healthcare Investments
509 Sumter St
Montezuma, Georgia 31063
478-472-3100
Phone: 478-472-3100
Enter a starting address:
Medical School: Medical College Of Georgia School Of Medicine
Graduation Year: 1989
The Primary Medical Specialty for Michael Burke MD is listed as: Psychiatry
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 35
PAC (PECOS ID)#: 7012933237
NPI #: 1376649962
NPI Created On: 09/15/2006
NPI Last Updated Listed as: 08/17/2023
Primary Taxonomy Code: 2084P0800X
License Number:
054798
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $329
Number of Payments:: 1
Form of Payment: In-kind items and services
Travel and Lodging City: Boston
Travel and Lodging State: MA
Travel and Lodging Country: United States
Record ID:: 818223437
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: CNS
Name of Drug #1: LYBALVI
Open Associated Drug #1: 65757-652-42
Drug or Biological: Drug
Product Category #2: CNS
Name Of Drug #2:: LYBALVI
Associated Drug #2: 65757-653-42
Drug or Biological #3:: Drug
Product Category #3: CNS
Name of Drug: LYBALVI
Name Of Drug #3: 65757-654-42
Drug or Biological: Drug
Product Category #4: CNS
Name of Drug #4: LYBALVI
Associated Drug #4: 65757-651-42
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Travel and Lodging City: Boston
Travel and Lodging State: MA
Travel and Lodging Country: United States
Third Party:: Emergence Treatment and Research
Record ID:: 818223439
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: CNS
Name of Drug #1: LYBALVI
Open Associated Drug #1: 65757-652-42
Drug or Biological: Drug
Product Category #2: CNS
Name Of Drug #2:: LYBALVI
Associated Drug #2: 65757-653-42
Drug or Biological #3:: Drug
Product Category #3: CNS
Name of Drug: LYBALVI
Name Of Drug #3: 65757-654-42
Drug or Biological: Drug
Product Category #4: CNS
Name of Drug #4: LYBALVI
Associated Drug #4: 65757-651-42
Payments Total: $23
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 818223447
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: CNS
Name of Drug #1: ARISTADA
Open Associated Drug #1: 65757-401-03
Drug or Biological: Drug
Product Category #2: CNS
Name Of Drug #2:: ARISTADA
Associated Drug #2: 65757-402-03
Drug or Biological #3:: Drug
Product Category #3: CNS
Name of Drug: ARISTADA
Name Of Drug #3: 65757-403-03
Drug or Biological: Drug
Product Category #4: CNS
Name of Drug #4: ARISTADA
Associated Drug #4: 65757-404-03
Drug or Biological #4:: Drug
Product Category #5: CNS
Name of Drug #5: ARISTADA INITIO
Associated Drug #5: 65757-500-03
Payments Total: $20
Number of Payments:: 1
Form of Payment: In-kind items and services
Third Party:: Emergence Treatment and Research
Record ID:: 818223441
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: CNS
Name of Drug #1: LYBALVI
Open Associated Drug #1: 65757-652-42
Drug or Biological: Drug
Product Category #2: CNS
Name Of Drug #2:: LYBALVI
Associated Drug #2: 65757-653-42
Drug or Biological #3:: Drug
Product Category #3: CNS
Name of Drug: LYBALVI
Name Of Drug #3: 65757-654-42
Drug or Biological: Drug
Product Category #4: CNS
Name of Drug #4: LYBALVI
Associated Drug #4: 65757-651-42
Payments Total: $72
Number of Payments:: 1
Form of Payment: In-kind items and services
Travel and Lodging City: Boston
Travel and Lodging State: MA
Travel and Lodging Country: United States
Third Party:: Emergence Treatment and Research
Record ID:: 818223443
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: CNS
Name of Drug #1: LYBALVI
Open Associated Drug #1: 65757-652-42
Drug or Biological: Drug
Product Category #2: CNS
Name Of Drug #2:: LYBALVI
Associated Drug #2: 65757-653-42
Drug or Biological #3:: Drug
Product Category #3: CNS
Name of Drug: LYBALVI
Name Of Drug #3: 65757-654-42
Drug or Biological: Drug
Product Category #4: CNS
Name of Drug #4: LYBALVI
Associated Drug #4: 65757-651-42
Payments Total: $7,100
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third Party:: Emergence Treatment and Research
Record ID:: 818223445
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: CNS
Name of Drug #1: LYBALVI
Open Associated Drug #1: 65757-652-42
Drug or Biological: Drug
Product Category #2: CNS
Name Of Drug #2:: LYBALVI
Associated Drug #2: 65757-653-42
Drug or Biological #3:: Drug
Product Category #3: CNS
Name of Drug: LYBALVI
Name Of Drug #3: 65757-654-42
Drug or Biological: Drug
Product Category #4: CNS
Name of Drug #4: LYBALVI
Associated Drug #4: 65757-651-42
Payments Total: $65
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 818223449
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: CNS
Name of Drug #1: ARISTADA
Open Associated Drug #1: 65757-401-03
Drug or Biological: Drug
Product Category #2: CNS
Name Of Drug #2:: ARISTADA
Associated Drug #2: 65757-402-03
Drug or Biological #3:: Drug
Product Category #3: CNS
Name of Drug: ARISTADA INITIO
Name Of Drug #3: 65757-500-03
Drug or Biological: Drug
Product Category #4: CNS
Name of Drug #4: LYBALVI
Associated Drug #4: 65757-652-42
Drug or Biological #4:: Drug
Product Category #5: CNS
Name of Drug #5: LYBALVI
Associated Drug #5: 65757-653-42
509 Sumter St
Montezuma, GA
Premier Healthcare Investments
509 Sumter St
Montezuma, GA
Premier Healthcare Investments
509 Sumter St
Montezuma, GA
Premier Healthcare Investments
509 Sumter St
Montezuma Ga 31063-1733
Premier Healthcare Investments
Psychiatry
509 Sumter St
Montezuma Ga 31063-1733
Premier Healthcare Investments
Psychiatry
509 Sumter St
Montezuma Ga 31063-1733
Premier Healthcare Investments
Psychiatry
509 Sumter St
Montezuma Ga 31063-1733
Premier Healthcare Investments
Nurse Practitioner
509 Sumter St
Montezuma Ga 31063-1733
Premier Healthcare Investments
Nurse Practitioner
509 Sumter St
Montezuma Ga 31063-1733
Premier Healthcare Investments
Family Practice
View all 7 members of Premier Healthcare Investments medical group